Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03360006
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 30
Not applicableNot Yet RecruitingNCT07724652
What this trial is testing

The AYA Oncology Self-care Movement

Who this might be right for
Acute Lymphobkastic LeukemiaMedication Adherence
Northwestern University 200
Early research (Phase 1)Active Not RecruitingNCT02050347
What this trial is testing

Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)

Who this might be right for
Non-Hodgkin's LymphomaB-Cell ALLB-Cell CLL
Baylor College of Medicine 7
Early research (Phase 1)Study completedNCT01328626
What this trial is testing

Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
AbbVie 222
Not applicableStudy completedNCT03234335
What this trial is testing

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal Failure
Centre Hospitalier Universitaire de Saint Etienne 50
Early research (Phase 1)Study completedNCT00889408
What this trial is testing

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 25
Testing effectiveness (Phase 2)Study completedNCT00014508
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT06168825
What this trial is testing

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

Who this might be right for
CancerBreast CancerBrain Cancer+13 more
Inova Health Care Services 40
Early research (Phase 1)Looking for participantsNCT07249840
What this trial is testing

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Who this might be right for
JAK2 Mutation
Brigham and Women's Hospital 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06769568
What this trial is testing

Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic Anemia

Who this might be right for
Aplastic AnaemiaHSCTTBI+1 more
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT00475150
What this trial is testing

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+8 more
National Cancer Institute (NCI) 39
Not applicableLooking for participantsNCT06956755
What this trial is testing

Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
Groupe Francophone des Myelodysplasies 6,990
Testing effectiveness (Phase 2)Looking for participantsNCT00501826
What this trial is testing

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
T Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma
M.D. Anderson Cancer Center 160
Not applicableLooking for participantsNCT07579585
What this trial is testing

Effects of Photobiomodulation in Hemophilia Patients.

Who this might be right for
Hemarthrosis, KneeHemophilia
Riphah International University 24
Not applicableNot Yet RecruitingNCT07351435
What this trial is testing

The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

Who this might be right for
Cardiogenic ShockMalignant ArrhythmiasIschemic or Valvular Heart Failure+8 more
University of Genova 1,200
Early research (Phase 1)UnknownNCT04727008
What this trial is testing

CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sichuan University 12
Not applicableUnknownNCT02959125
What this trial is testing

NutFish and Nutrient Supplementation in Pregnancy Class to Improve Maternal and Birth Outcomes

Who this might be right for
PregnancyProtein-Energy MalnutritionAnemia
Semarang Health Polytechnic 72
Testing effectiveness (Phase 2)Ended earlyNCT00262925
What this trial is testing

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT07285668
What this trial is testing

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Wisconsin, Madison 38
Testing effectiveness (Phase 2)Study completedNCT02169791
What this trial is testing

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Northside Hospital, Inc. 29
Next Page